Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
| Portfolio of Gene Editing (CRISPR) Stocks | |||
Stock | Price Quote & Dividend | 1-Yr Price Chart | |
| Crispr Therapeutics | |||
| Editas Medicine | |||
| Intellia Therapeutics | |||
| Vertex Pharmaceuticals | |||
| Price data from Quandl. | |||
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl. All 4 are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each at its closing weekly price for the current date in 2017.
|
Portfolio of Gene Editing (CRISPR) Stocks - Return Results | |
| Portfolio: | Portfolio of Gene Editing (CRISPR) Stocks |
| Start date: | Jun-24-2017 |
| Start value: | $10,000 |
| End date: | Jun-24-2018 |
| End value: | $23,268 |
| Number prices | 13 |
| Minimum value occurred on Jun-30-2017 | $10,000 |
| Maximum value occurred on May-31-2018 | $23,685 |
| Total gain or loss (Start date to End date) | 132.68% |
| Annualized gain or loss (Start date to End date) | 132.68% |
| Total dollar value on End date of a $10,000 purchase made on Start date | $23,268 |
| Average percent return for all possible buy/sell combinations | 32.33% |
| Number returns | 78 |
| Number profitable returns (Winners) | 59 |
| Percent profitable returns | 75.64% |
| Number unprofitable returns (Losers) | 19 |
| Percent unprofitable returns | 24.36% |
| Winners to losers ratio | 3.11 |
| Stock Return Calculator | |
Related Articles
Portfolio of Biotech Stocks: Cancer
Portfolio of Gene Editing Stocks
Portfolio of Gene Sequencing Stocks
Portfolio of Gene Therapy Stocks
Portfolio of Genetic Testing Stocks
Portfolio of Genomics Stocks
Portfolio of Personalized Medicine Stocks
Portfolio of Stem Cell Stocks
Portfolio of Synthetic Biology Stocks